Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

MREO — Mereo BioPharma Group plc Dilution Risk Tracker

Track MREO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MREO — Get alerts when the score changes →

As of August 28, 2026, Mereo BioPharma Group plc (MREO) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Mereo BioPharma Group plc has a market capitalization of $54.91M, 798.45M shares outstanding, 67 institutional holders tracked. Stored dilution-related fields include 1.55M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊Float Risk
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.30 below $1 exchange minimum
🔔 Track MREO — Get forecast alerts →

Market Data

Market Cap$54.91M
Shares Outstanding798.45M
FloatN/A
Cash$30.12M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 19.7% shares (2026Q1 vs prior)
67 institutional holders · 81.31M shares
#1 Rubric Capital Management LP 15.31M shares
#2 EcoR1 Capital, LLC 13.37M shares
#3 683 Capital Management, LLC 12.00M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.41M
Days to Cover3.4
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2024-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual MREO Dilution Snapshot

Mereo BioPharma Group plc (MREO) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track MREO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MREO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note